Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.


Journal

Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645

Informations de publication

Date de publication:
07 Aug 2019
Historique:
received: 13 11 2018
accepted: 12 07 2019
entrez: 8 8 2019
pubmed: 8 8 2019
medline: 23 11 2019
Statut: epublish

Résumé

The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in response to the call proposed at the 50th World Health Assembly. The goal of the GPELF is to ensure that all the countries where the disease is endemic would have been transmission-free or would have entered post-intervention mass drug administration (MDA) surveillance by 2020. However, several countries are still not on track to discontinue MDA as planned. Thus, issues remain regarding the achievement of stated goals and how to effectively monitor the disease in the post-control and post-elimination phases. China was once a lymphatic filariasis (LF) endemic country with heavy disease burden. There were three milestones in the LF control phase of China, including: the proposal that the major focus of the control strategy should be on infectious sources; the three regimens of diethylcarbamazine (DEC) administration according to LF endemic extent; and the establishment of the threshold for LF transmission interruption. It has been ten years since China entered the post-elimination stage (declaration of LF elimination in China was in 2007). Two schemes and a diagnostic criterion were issued to guide all levels of disease control and prevention workers that conduct LF surveillance, as well as those caring for chronic filariasis patients. Regular training courses are held to maintain LF control skills in grass-root institutions. The Notifiable Diseases Reporting System, which included LF in 2004, plays an important role in LF post-elimination surveillance. Until now, no resurgence of LF cases has been detected, except for LF residue foci being found in Fuchuan County of the Guangxi Zhuang Autonomous Region. To confirm that transmission is no longer achievable after a decade since the declaration of LF elimination in China, it is expected within the next two years a transmission assessment survey, conducted in previous LF-endemic areas. DEC-fortified salt can help accelerate the progress of GPELF before the sprite phase. Sophisticated diagnostic criteria, systematic surveillance regimes, the Direct Network Report system, and regular trainings can effectively prevent the recrudescence of LF during surveillance phases.

Sections du résumé

BACKGROUND BACKGROUND
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in response to the call proposed at the 50th World Health Assembly. The goal of the GPELF is to ensure that all the countries where the disease is endemic would have been transmission-free or would have entered post-intervention mass drug administration (MDA) surveillance by 2020. However, several countries are still not on track to discontinue MDA as planned. Thus, issues remain regarding the achievement of stated goals and how to effectively monitor the disease in the post-control and post-elimination phases.
MAIN TEXT METHODS
China was once a lymphatic filariasis (LF) endemic country with heavy disease burden. There were three milestones in the LF control phase of China, including: the proposal that the major focus of the control strategy should be on infectious sources; the three regimens of diethylcarbamazine (DEC) administration according to LF endemic extent; and the establishment of the threshold for LF transmission interruption. It has been ten years since China entered the post-elimination stage (declaration of LF elimination in China was in 2007). Two schemes and a diagnostic criterion were issued to guide all levels of disease control and prevention workers that conduct LF surveillance, as well as those caring for chronic filariasis patients. Regular training courses are held to maintain LF control skills in grass-root institutions. The Notifiable Diseases Reporting System, which included LF in 2004, plays an important role in LF post-elimination surveillance. Until now, no resurgence of LF cases has been detected, except for LF residue foci being found in Fuchuan County of the Guangxi Zhuang Autonomous Region. To confirm that transmission is no longer achievable after a decade since the declaration of LF elimination in China, it is expected within the next two years a transmission assessment survey, conducted in previous LF-endemic areas.
CONCLUSIONS CONCLUSIONS
DEC-fortified salt can help accelerate the progress of GPELF before the sprite phase. Sophisticated diagnostic criteria, systematic surveillance regimes, the Direct Network Report system, and regular trainings can effectively prevent the recrudescence of LF during surveillance phases.

Identifiants

pubmed: 31387644
doi: 10.1186/s40249-019-0578-9
pii: 10.1186/s40249-019-0578-9
pmc: PMC6685173
doi:

Substances chimiques

Filaricides 0
Diethylcarbamazine V867Q8X3ZD

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

66

Subventions

Organisme : National Key Research and Development Program of China
ID : 2016YFC1202000, 2016YFC1202002, 2016YFC1202003

Commentaires et corrections

Type : CommentIn

Références

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2001;19(2):110-2
pubmed: 12572001
PLoS Negl Trop Dis. 2016 Mar 30;10(3):e0004590
pubmed: 27028010
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1994;12(1):1-6
pubmed: 8044896
J Parasit Dis. 2009 Dec;33(1-2):3-12
pubmed: 23129882
Wkly Epidemiol Rec. ;92(40):589-93
pubmed: 28984120
Wkly Epidemiol Rec. 2004 Oct 1;79(40):358-65
pubmed: 15631012
Trends Parasitol. 2017 Feb;33(2):83-92
pubmed: 27765440
Wkly Epidemiol Rec. 2015 Sep 18;90(38):489-504
pubmed: 26387149
Chin Med J (Engl). 1991 Jun;104(6):446-53
pubmed: 1874020
Wkly Epidemiol Rec. 2001 May 18;76(20):149-54
pubmed: 11395916
Lancet Glob Health. 2016 Mar;4(3):e154-5
pubmed: 26874545
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1995;13(2):81-5
pubmed: 7554168
PLoS Negl Trop Dis. 2011 Dec;5(12):e1366
pubmed: 22216361
Infect Dis Poverty. 2013 Dec 02;2(1):30
pubmed: 24289733
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Dec 30;26(6):404-8
pubmed: 19288909
PLoS Negl Trop Dis. 2013;7(1):e1984
pubmed: 23301115
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1988;6(2):99-102
pubmed: 3052910
Southeast Asian J Trop Med Public Health. 1992 Sep;23(3):369-76
pubmed: 1362625
Filaria J. 2003 Sep 9;2(1):13
pubmed: 13129436
Am J Trop Med Hyg. 2013 Jul;89(1):3-4
pubmed: 23843491
Annu Rev Entomol. 2009;54:469-87
pubmed: 18798707
Am J Trop Med Hyg. 2013 Jul;89(1):11-15
pubmed: 23690552
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1987;5(2):89-92
pubmed: 3308162
Res Rep Trop Med. 2018 Mar 06;9:25-33
pubmed: 30050352
Bull World Health Organ. 1968;38(6):935-41
pubmed: 4235739
Am J Trop Med Hyg. 2000 Apr;62(4):502-3
pubmed: 11220767

Auteurs

Yuan Fang (Y)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Key Laboratory of Parasite and Vector Biology, Ministry of Health, 207 Ruijin Er Road, Shanghai, 200025, People's Republic of China.

Yi Zhang (Y)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Key Laboratory of Parasite and Vector Biology, Ministry of Health, 207 Ruijin Er Road, Shanghai, 200025, People's Republic of China. zhang1972003@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH